ADC	antibody-drug conjugate
ALDH	aldehyde dehydrogenase
ALDH1A1	aldehyde dehydrogenase 1 family member A1
ALDH1A3	aldehyde dehydrogenase 1 family member A3
ASCO	American Society of Clinical Oncology
BCLM	breast cancer liver metastasis
CDK4/6	cyclin-dependent kinase 4/6
cfDNA	cell-free DNA
CLDN2	claudin-2
CSCO	Chinese Society of Clinical Oncology
CT	computed tomography
CTC	circulating tumor cell
ctDNA	circulating tumor DNA
DEAB	N,N-diethylaminobenzaldehyde
EMT	epithelial–mesenchymal transition
EpCAM	epithelial cell adhesion molecule
ER	estrogen receptor
ESMO	European Society for Medical Oncology
ESR1	estrogen receptor 1
HER2	human epidermal growth factor receptor 2
HR	hormone receptor
IL-10	interleukin-10
JAK-STAT	Janus kinase-signal transducer and activator of transcription
MASLD	metabolic dysfunction-associated steatotic liver disease
MRI	magnetic resonance imaging
OS	overall survival
PET/CT	positron emission tomography/computed tomography
PI3K	phosphoinositide 3-kinase
PIK3CA	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
PPARG	peroxisome proliferator-activated receptor gamma
PR	progesterone receptor
RFA	radiofrequency ablation
RNA	ribonucleic acid
SBRT	stereotactic body radiotherapy
SEER	Surveillance, Epidemiology, and End Results
SIRT	selective internal radiation therapy
SRFA	stereotactic radiofrequency ablation
TACE	transarterial chemoembolization
TGF-beta1	transforming growth factor beta 1
TNBC	triple-negative breast cancer